Novavax Inc (NVAX)

CIK 1000694 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Novavax Inc.

Recent SEC filings

FiledFormAccession number
Aug 7, 2026SCHEDULE 13G0000093751-26-000510
Aug 6, 20268-K0001000694-26-000019
Aug 6, 2026S-80001104659-26-091965
Aug 6, 202610-Q0001000694-26-000018
Jun 23, 202640001104659-26-076928
Jun 23, 202640001104659-26-076927
Jun 23, 202640001104659-26-076926
Jun 23, 202640001104659-26-076924
Jun 23, 202640001104659-26-076925
Jun 23, 20268-K0001104659-26-076648
Jun 23, 202640001104659-26-076922
Jun 23, 202640001104659-26-076930
Jun 23, 202640001104659-26-076923
May 27, 20261440001628280-26-038512
May 15, 2026SCHEDULE 13D/A0001398344-26-009210
May 7, 20261440001628280-26-032295
May 6, 20268-K0001628280-26-030924
May 6, 202610-Q0001628280-26-030917
Apr 30, 2026SCHEDULE 13G0002100119-26-000933
Apr 28, 202640001104659-26-050457
Apr 27, 2026ARS0001104659-26-049137
Apr 27, 2026SCHEDULE 13G/A0000070858-26-000241
Apr 27, 2026DEF 14A0001628280-26-027328
Apr 27, 2026DEFA14A0001628280-26-027330
Apr 16, 202640001104659-26-044486